Reported Aug 8, 2012 · Terminated
Caziant (desogestrel and ethinyl estradiol) Tablets, USP, (Triphasic Regimen), 0.1 mg/0.025 mg, 0.125 mg/0.025 mg, 0.15…
Watson Laboratories Inc.
Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Watson Laboratories Inc · 311 Bonnie Cir · Corona, CA · 92880-2882
Is this the product you have?
- Caziant (desogestrel and ethinyl estradiol) Tablets, USP, (Triphasic Regimen), 0.1 mg/0.025 mg, 0.125 mg/0.025 mg, 0.15 mg/0.025 mg, 28-count tablets per dispenser (NDC 52544-959-28), packaged in 3-count Tablet Dispensers per carton (NDC 52544-959-31)
- Rx only Manufactured byWatson Laboratories, Inc., Corona, CA 92880
- Distributed byWatson Pharma, Inc., Corona, CA 92880
- Lot codes and dates
Lot #s: 412572A412572BExp 11/12
- Amount recalled
- 18,938 cartons
Where it was sold
- Nationwide
Why it was recalled
Impurities/Degradation Products: High Out-of-specification results were obtained for both known and unknown impurities.
This product is unlikely to cause harm, but it breaks a safety or labelling rule.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Watson Laboratories Inc. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.